In-silico analysis of nonsynonymous genomic variants within CCM2 gene reaffirm the existence of dual cores within typical PTB domain

Zhang, 2001, Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation, Hum. Mol. Genet., 10, 2953, 10.1093/hmg/10.25.2953

Padarti, 2021

Fisher, 2015, Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations, J. Biol. Chem., 290, 2842, 10.1074/jbc.M114.616433

Zhang, 2007, Interaction between krit1 and malcavernin: implications for the pathogenesis of cerebral cavernous malformations, Neurosurgery, 60, 353, 10.1227/01.NEU.0000249268.11074.83

Jiang, 2019, Alternatively spliced isoforms reveal a novel type of PTB domain in CCM2 protein, Sci. Rep., 9, 15808, 10.1038/s41598-019-52386-0

Yang, 2020, A novel CCM2 gene mutation associated with cerebral cavernous malformation, Front. Neurol., 11, 70, 10.3389/fneur.2020.00070

Knorre, 2009, Chemical and functional aspects of posttranslational modification of proteins, Acta Nat., 1, 29, 10.32607/20758251-2009-1-3-29-51

Dahiyat, 2006, In-silico protein design: fitting sequence onto structure, Methods Mol. Biol., 316, 359

Abdulazeez, 2019, The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching, PLoS One, 14, 10.1371/journal.pone.0212492

AbdulAzeez, 2016, In-silico computing of the most deleterious nsSNPs in HBA1 gene, PLoS One, 11, 10.1371/journal.pone.0147702

Caswell, 2019, Using structural analysis in-silico to assess the impact of missense variants in MEN1, J. Endocr. Soc., 3, 2258, 10.1210/js.2019-00260

Seifi, 2018, Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in-silico bioinformatics algorithms, PLoS One, 13, 10.1371/journal.pone.0195971

Kumar, 2009, Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm, Nat. Protoc., 4, 1073, 10.1038/nprot.2009.86

Thomas, 2006, Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools, Nucleic Acids Res., 34, W645, 10.1093/nar/gkl229

Choi, 2015, PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels, Bioinformatics, 31, 2745, 10.1093/bioinformatics/btv195

Adzhubei, 2010, A method and server for predicting damaging missense mutations, Nat. Methods, 7, 248, 10.1038/nmeth0410-248

Schwarz, 2014, MutationTaster2: mutation prediction for the deep-sequencing age, Nat. Methods, 11, 361, 10.1038/nmeth.2890

Capriotti, 2005, I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure, Nucleic Acids Res., 33, W306, 10.1093/nar/gki375

Parthiban, 2006, CUPSAT: prediction of protein stability upon point mutations, Nucleic Acids Res., 34, W239, 10.1093/nar/gkl190

Pettersen, 2004, UCSF Chimera--a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084

Yang, 2015, The I-TASSER Suite: protein structure and function prediction, Nat. Methods, 12, 7, 10.1038/nmeth.3213

Stahl, 2008, Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex, Hum. Mutat., 29, 709, 10.1002/humu.20712

Nardella, 2018, A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion, Hum. Mutat., 39, 1885, 10.1002/humu.23629

Much, 2019, Novel pathogenic variants in a cassette exon of CCM2 in patients with cerebral cavernous malformations, Front. Neurol., 10, 1219, 10.3389/fneur.2019.01219

Tsutsumi, 2013, Genomic causes of multiple cerebral cavernous malformations in a Japanese population, J. Clin. Neurosci., 20, 667, 10.1016/j.jocn.2012.05.041

Zawistowski, 2005, CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis, Hum. Mol. Genet., 14, 2521, 10.1093/hmg/ddi256

Riant, 2013, CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions, Neurogenetics, 14, 133, 10.1007/s10048-013-0362-0

Han, 2020, A novel CCM2 missense variant caused cerebral cavernous malformations in a Chinese family, Front. Neurosci., 14, 604350, 10.3389/fnins.2020.604350

Scimone, 2017, Update on novel CCM gene mutations in patients with cerebral cavernous malformations, J. Mol. Neurosci., 61, 189, 10.1007/s12031-016-0863-z

Scimone, 2018, Two novel KRIT1 and CCM2 mutations in patients affected by cerebral cavernous malformations: new information on CCM2 penetrance, Front. Neurol., 9, 953, 10.3389/fneur.2018.00953

Huang, 2016, A novel CCM2 gene mutation associated with familial cerebral cavernous malformation, Front. Aging Neurosci., 8, 220, 10.3389/fnagi.2016.00220

Merello, 2017, Erratum to: genetic screening of pediatric cavernous malformations, J. Mol. Neurosci., 61, 132, 10.1007/s12031-016-0852-2

Rath, 2017, High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations, Eur. J. Med. Genet., 60, 479, 10.1016/j.ejmg.2017.06.007

Sain, 2016, Understanding the molecular basis of substrate binding specificity of PTB domains, Sci. Rep., 6, 31418, 10.1038/srep31418